Lisa Marcolini

Peschiera Del Garda, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Integrated morphologic, immunophenotypic, and molecular profiling of advanced upper tract urothelial carcinoma across tumor compartments supports biopsy-based testing.

Integrated morphologic, immunophenotypic, and molecular profiling of advanced upper tract urothelial carcinoma across tumor compartments supports biopsy-based testing.

Journal: Pathology, research and practice

Published: July 25, 2026

Papillary renal neoplasm with reverse polarity: a novel entity for the next WHO classification? a clinical-pathological and molecular study of 15 cases, compared to eosinophilic/oncocytic papillary renal cell carcinoma.

Papillary renal neoplasm with reverse polarity: a novel entity for the next WHO classification? a clinical-pathological and molecular study of 15 cases, compared to eosinophilic/oncocytic papillary renal cell carcinoma.

Journal: Virchows Archiv : an international journal of pathology

Published: February 03, 2026

Stimulator of interferon genes (STING) in renal tumors: Biological bases, diagnostic relevance, and predictive potential.

Stimulator of interferon genes (STING) in renal tumors: Biological bases, diagnostic relevance, and predictive potential.

Journal: Histology and histopathology

Published: December 24, 2025

Diagnostic practice and awareness of SDH- and FH-deficient renal cell carcinoma: results from an Italian Study Group of uropathology (GIUP) survey.

Diagnostic practice and awareness of SDH- and FH-deficient renal cell carcinoma: results from an Italian Study Group of uropathology (GIUP) survey.

Journal: Virchows Archiv : an international journal of pathology

Published: December 01, 2025

Mucinous Carcinoma, Mucinous Borderline Tumor and Pseudomyxoma Ovarii in a Cystic Teratoma: A Histological Conundrum.

Mucinous Carcinoma, Mucinous Borderline Tumor and Pseudomyxoma Ovarii in a Cystic Teratoma: A Histological Conundrum.

Journal: Diagnostics (Basel, Switzerland)

Published: July 04, 2025

Stimulator of interferon genes immunohistochemical expression in the spectrum of extrarenal perivascular epithelioid cell lesions.

Stimulator of interferon genes immunohistochemical expression in the spectrum of extrarenal perivascular epithelioid cell lesions.

Journal: Scientific reports

Published: May 26, 2025

Determinants of oncologic outcomes in high-grade organ-confined prostate cancer after prostatectomy.

Determinants of oncologic outcomes in high-grade organ-confined prostate cancer after prostatectomy.

Journal: Histopathology

Published: May 19, 2025

SFPQ::TFE3-rearranged PEComa: Differences and analogies with renal cell carcinoma carrying the same translocation.

SFPQ::TFE3-rearranged PEComa: Differences and analogies with renal cell carcinoma carrying the same translocation.

Journal: Pathology, research and practice

Published: February 07, 2025

Stimulator of interferon genes (STING) immunohistochemical expression in fumarate hydratase-deficient renal cell carcinoma: biological and potential predictive implications.

Stimulator of interferon genes (STING) immunohistochemical expression in fumarate hydratase-deficient renal cell carcinoma: biological and potential predictive implications.

Journal: Virchows Archiv : an international journal of pathology

Published: December 09, 2024

TFE3-Rearranged Tumors of the Kidney: An Emerging Conundrum.

TFE3-Rearranged Tumors of the Kidney: An Emerging Conundrum.

Journal: Cancers

Published: September 05, 2024

Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma.

Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc

Published: February 23, 2024

mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy.

mTOR eosinophilic renal cell carcinoma: a distinctive tumor characterized by mTOR mutation, loss of chromosome 1, cathepsin-K expression, and response to target therapy.

Journal: Virchows Archiv : an international journal of pathology

Published: September 19, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026